Miltwon en es it fr

Miltwon Brand names, Miltwon Analogs

Miltwon Brand Names Mixture

  • No information avaliable

Miltwon Chemical_Formula


Miltwon RX_link

No information avaliable

Miltwon fda sheet

Miltwon msds (material safety sheet)

Miltwon Synthesis Reference

No information avaliable

Miltwon Molecular Weight

309.469 g/mol

Miltwon Melting Point

< 25 oC

Miltwon H2O Solubility

Soluble as HCl salt

Miltwon State


Miltwon LogP


Miltwon Dosage Forms

Tablets (oral, 1 mg)

Miltwon Indication

Used for the symptomatic treatment of parkinsonism.

Miltwon Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltwon Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltwon side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltwon Patient Information

Miltwon Organisms Affected

Humans and other mammals